Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease

Pediatric Cardiology

Volumn 20, Issue 4, 1999, Pages 248-251

  Yanagawa, H ^a   Tuohong, Z ^a   Oki, I ^a   Nakamura, Y ^a   Yashiro, M ^a   Ojima, T ^a   Tanihara, S ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac sequelae; Epidemiology; Gamma globulin treatment; Kawasaki disease

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN;

AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHILD; CHRONOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEWBORN; SEX DIFFERENCE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGE DISTRIBUTION; CHILD, PRESCHOOL; COMORBIDITY; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-GLOBULINS; HEART DISEASES; HUMANS; INCIDENCE; INFANT; JAPAN; LOGISTIC MODELS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033003793     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002469900458     Document Type: Article

References (21)

1. Fatica NS, Ichida F, O'Loughlin JE, Engle MA (1987) Detection and management of cardiac involvement in the Kawasaki disease. Pediatr Ann 16:639-643
2. Furusho K, Kamiya T, Nakano H, et al. (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
3. Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805-810
4. Hosmer DW Jr, Lemenshow S (1989) Applied Logistic Regression. Wiley, New York, pp 82-91
5. Ichida F, Fatica NS, Engle MA, et al. (1987) Coronary artery involvement in Kawasaki syndrome in Manhattan, New York. Pediatrics 80:828-835
6. Koren G, Lavi S, Rose V, Rove R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388-392
7. Koyanagi H, Nakamura Y, Yanagawa H (1998) Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 87:32-36
8. Koyanagi H, Yanagawa H, Nakamura Y, Yashiro M (1997) Serum C-reactive protein levels in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr 86:613-619
9. Koyanagi H, Yanagawa H, Nakamura Y, Yashiro M (1997) Leucocyte counts in patients with Kawasaki disease: from the results of nation-wide surveys of Kawasaki disease in Japan. Acta Paediatr 86:1328-1332
10. Matsushima M, Nagashima M, Matsuoka H, et al. (1986) Controlled study on high dose gamma-globulin treatment for Kawasaki disease - report 1 Gamma-globulin administration of 400 mg/kg for 5 days. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 90:80-87 [in Japanese]
11. Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura M (1987) High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr 110:710-712
12. Nakano H, Ueda K, Saito A, et al. (1986) Scoring methods for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cordiol 58:739-742
13. Newburger JW, Takahashi M, Burns JC, et al. (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
14. Ogawa M, Ogino H, Harima Y, et al. (1987) Evaluation of gammaglobulin treatment for Kawasaki disease - efficacy of the administration of the dose of 400 mg/kg for 3 days. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 91:3763-3771 [in Japanese]
15. Ogino H, Ogawa M, Harima Y, et al. (1987) Evaluation of gammaglobulin treatment for Kawasaki disease - efficacy of the administration of the dose of 200 mg/kg for 3 days. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 91:2849-2856 [in Japanese]
16. Onouchi Z, Yanagisawa M, Shiraishi H, et al. (1992) Multicenter randomized controlled study of intravenous immunoglobulin G(C-425) for Kawasaki disease (1) Study for optimal dosage and usefulness of C-425. Nippon Shonika Gakkai Zasshi (J Jpn Pediatr Soc) 96:2669-2679 [in Japanese]
17. SAS Institute Inc. (1995) Logistic Regression Examples Using the SAS System. SAS Institute Cary, NC
18. Yanagawa H, Nakamura Y, Yashiro M, et al. (1997) Update of the epidemiology of Kawasaki disease in Japan: from the results of 1993-94 nationwide survey. J Epidemiol 6:148-157
19. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H (1995) Results of twelve nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolescent Med 149:779-783
20. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H (1995) Epidemiological pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics 95:475-479
21. Yanagawa H, Yashiro M, Nakamura Y (1998) 14th nationwide survey on Kawasaki disease. Syonika Shinryo (J Pediatr Practice) 67:406-420 [in Japanese]